Publications
Members of our research team write publications on their research.
Click here to download a full list of our publications
Our publications for 2011 - 2013 are listed below.
RICE Publications 2013
Original Papers
Clare, L., Bayer, A., Burns, A., Corbett, A., Jones, R., Knapp, M., Kopelman, M., Kudlicka, A., Leroi, I., Oyebode, J., Pool, J., Woods, B. & Whitaker, R.
Goal-oriented cognitive rehabilitation in early-stage dementia: study protocol for a multi-centre single-blind randomised controlled trial (GREAT). 2013 Trials, 14: 152.
Damian, M., Hausner, L., Jekel, K., Richter, M., Froelich, L., Almkvist, O., Boada, M., Bullock, R., De Deyn, P.P., Frisoni, G.B., Hampel, H., Jones, R.W., Kehoe, P., Lenoir, H., Minthon, L., Olde Rikkert, M.G., Rodriguez, G., Scheltens, P., Soininen, H., Spiru, L., Touchon, J., Tsolaki, M., Vellas, B., Verhey, F.R., Winblad, B., Wahlund, L.O., Wilcock, G. & Visser, P.J.
Single-Domain Amnestic Mild Cognitive Impairment Identified by Cluster Analysis Predicts Alzheimer's Disease in the European Prospective DESCRIPA Study. Dement Geriatr Cogn Disord, 2013; 36: 1-19.
Hoffman, P., Jones, R.W. & Lambon Ralph, M.A.
Be concrete to be comprehended: Consistent imageability effects in semantic dementia for nouns, verbs, synonyms and associates. Cortex 2013; 49: 1206-18.
Martinez, C., Jones, R.W. & Rietbrock, S.
Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study. BMJ Open; 2013: 3.
Noonan, K.A., Jefferies, E., Garrard, P., Eshan, S. & Lambon Ralph, M.A.
Demonstrating the qualitative differences between semantic aphasia and semantic dementia: a novel exploration of nonverbal semantic processing. Behav Neurol. 2013; 26: 7-20.
Vermeiren, A.P., Bosma, H., Visser, P.J., Zeegers, M.P., Graff, C., Ewers, M., Frisoni, G.B., Frölich, L., Hampel, H., Jones, R.W., Kehoe, P.G., Lenoir, H., Minthon, L., Nobili, F.M., Olde Rikkert, M., Rigaud, A.S., Scheltens, P., Soininen, H., Spiru, L., Tsolaki, M., Wahlund, L.O., Vellas, B., Wilcock, G., Elias-Sonnenschein, L.S. & Verhey, F.R.
The Association Between APOE ε4 and Alzheimer-type Dementia Among Memory Clinic Patients is Confined to those with a Higher Education. The DESCRIPA Study. J Alzheimers Dis, 2013; 35: 241-6.
Wimo, A., Reed, C.C., Dodel, R., Belger, M., Jones, R.W., Happich, M., Argimon, J.M., Bruno, G., Novick, D., Vellas, B. & Haro, J.M.
The GERAS Study: A Prospective Observational Study of Costs and Resource Use in Community Dwellers with Alzheimer's Disease in Three European Countries - Study Design and Baseline Findings. J Alzheimers Dis. 2013 [Epub]
RICE Publications 2012
Original Papers
Francis, P.T., Parsons, C.G. & Jones, R.W.
Rationale for combining glutamatergic and cholinergic approaches in the symptomatic treatment of Alzheimer's disease. Expert Rev Neurother. 2012; 12: 1351-65.
Hoffman, P., Jones, R.W. & Lambon Ralph, M.A.
The degraded concept representation system in semantic dementia: damage to pan-modal hub, then visual spoke. Brain 2012; 135: 3770-80.
Hoffman P, Jefferies E, Ehsan S, Jones RW, Lambon Ralph MA.
How does linguistic knowledge contribute to short-term memory? Contrasting effects of impaired semantic knowledge and executive control. Aphasiology 2012; 26 (3-4):383-403.
Hoffman P, Jones RW & Lambon Ralph MA. 2012.
Be concrete to be comprehended: Consistent imageability effects in semantic dementia for nouns, verbs, synonyms and associates. Cortex 2012 May 26. [Epub]
Howard, R., McShane, R., Lindesay, J., Ritchie, C., Baldwin, A., Barber, R., Burns, A., Dening, T., Findlay, D., Holmes, C., Hughes, A., Jacoby, R., Jones, R., Jones, R., McKeith, I., Macharouthu, A., O'Brien, J., Passmore, P., Sheehan, B., Juszczak, E., Katona, C., Hills, R., Knapp, M., Ballard, C., Brown, R., Banerjee, S., Onions, C., Griffin, M., Adams, J., Gray, R., Johnson, T., Bentham, P. & Phillips, P.
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease. New England Journal of Medicine, 2012; 366: 893-903.
Noonan KA, Pryer LR, Jones RW, Burns AS, Lambon Ralph MA
A direct comparison of errorless and errorful therapy for object name relearning in Alzheimer’s disease. Neuropsychological Rehabilitation 2012; 22(2): 215-234.
Trigg R, Watts S, Jones R, Tod A, Elliman R. Self-reported quality of life ratings of people with dementia: the role of attitudes to aging. International Psychogeriatrics 2012; 24:7 1085-1093.
Vellas, B., Hausner, L., Frölich, L., Cantet, C., Gardette, V., Reynish, E., Gillette, S., Ag Era-Morales, E., Auriacombe, S., Boada-Rovira, M., Bullock, R., Byrne, J., Cherubini, A., Eriksdotter-J Nhagen, M., Frisoni, G., Hasselbalch, S., Jones, R., Martinez-Lage, P., Rikkert, M., Tsolaki, M., Ousset, P.J., Pasquier, F., Ribera-Casado, J.M., Rigaud, A.S., Robert, P., Rodriguez, G., Salmon, E., A, S., Scheltens, P., Schneider, A., Spiru, L., Touchon, J., Zekry, D., Winblad, B. & Andrieu, S.
Progression of Alzheimer disease in Europe: Data from the European ICTUS study. Curr Alzheimer Res. 2012; 9 (8): 902-912.
Conference Abstracts 2012
Jones, R.W., Lacey, L., Knapp, M., Romeo, R., Sato, A., Niecko, T., Trigg, R. (Dade Investigator Group)
Patient dependence and clinical measures of cognitive impairment, functional disability and behaviour in Alzheimer's disease: results from dependence in AD in England (DADE) study. European Journal of Neurology 2012; 19: S1.
Knapp, M., Romeo, R., Sato, A., Jones, R.W., Lacey, L.A. (Dade Investigator Group).
Relationship between healthcare, social care costs, dependence on others as illness progresses in Alzheimer's disease (AD): results from dependence in AD in England (DADE) study. European Journal of Neurology 2012; 19:S1
Lacey, L., Jones, R.W., Trigg, R., Niecko, T. (Dade Study Group)
Caregiver burden as illness progresses in Alzheimer's disease (AD): association with patient dependence and other factors: results from dependence in AD in England (DADE) study. European Journal of Neurology 2012; 19: S1
Lyketsos C, Tariot P, Jones R and Kinney G, Abushakra S.
What constitutes evidence of target engagement in AD trials? ELND005 CNS pharmacokinetics, biomarker and safety profile. Neurobiology of Aging 2012; 33: S1-S30.
Trigg, R., Jones, R.W., Lacey, L., Niecko, T. & Grp, D.I. (Dade Investigator Group). Relationship between self-assessed and proxy-assessed quality of life (QoL) and dependence in Alzheimer's disease (AD): results from dependence in AD in England (DADE) study. European Journal of Neurology; 2012 19:S1
RICE Publications 2011
Original Papers
Howard R, Phillips P, Johnson T, O'Brien J, Sheehan B, Lindesay J, Bentham P, Burns A, Ballard C, Holmes C, McKeith I, Barber R, Dening T, Ritchie C, Jones R, Baldwin A, Passmore P, Findlay D, Hughes A, Macharouthu A, Banerjee S, Knapp M, Brown R, Jacoby R, Adams J, Griffin M and Gray R. Determining the minimum clinically important differences for outcomes in the DOMINO trial. Int J Geriatr Psychiatr 2011; 26(8): 812-817.
Norberg J, Graff C, Almkvist O, Ewers M, Frisoni GB, Frölich L, Hampel H, Jones RW, Kehoe, PG, Lenoir H, Minthon L, Nobili F, Olde Rikkert M, Rigaud AS, Scheltens P, Soininen H, Spiru L, Tsolaki M, Wahlund LO, Vellas B, Wilcock G, Elias-Sonnenschein LS, Verhey FR, Visser PJ.
Regional Differences in Effects of APOE ε4 on Cognitive Impairment in Non-Demented Subjects. Dement Geriatr Cogn Disord 2011; 32(2): 135-142
Waldemar G, Gauthier S, Jones R, Wilkinson D, Cummings J, Lopez O, Zhang R, Xu Y, Sun Y, Knox S, Richardson S, Mackell J.
Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease. International Journal of Geriatric Psychiatry 2011; 26(2): 150-157.
Review Article 2011
Jones RW
Drug treatment for people with dementia.
Clinical Medicine 2011; 11(1): 67-71
Letter 2011
Jones R, Wilkinson D, Lopez O, Cummings J, Waldemar G, Zhang R, Mackell J, Gauthier S.
Collaborative research between academia and industry using a large clinical trial database: a case study in Alzheimer's disease. Trials 2011; 12: 233.
Conference Abstract 2011
Jones RW
Are extensive examinations necessary in the diagnosis of Alzheimer’s Disease? The case against! European Journal of Neurology. 2011; 18:18
